-   directed: true
    graph:
        drug: Tofogliflozin
        drugbank: DB:DB11824
        drug_mesh: MESH:C575086
        disease: Diabetes mellitus type 2
        disease_mesh: MESH:D003924
    links:
    -   key: decreases activity of
        source: MESH:C575086
        target: UniProt:P31639
    -   key: prevents
        source: UniProt:P31639
        target: GO:0035623
    -   key: decreases abundance of
        source: GO:0035623
        target: MESH:D001786
    -   key: correlated with
        source: MESH:D001786
        target: MESH:D003924
    multigraph: true
    nodes:
    -   id: MESH:C575086
        label: Drug
        name: Tofogliflozin
    -   id: UniProt:P31639
        label: Protein
        name: SGLT2
    -   id: GO:0035623
        label: BiologicalProcess
        name: Renal glucose absorption
    -   id: MESH:D001786
        label: ChemicalSubstance
        name: Blood Glucose
    -   id: MESH:D003924
        label: Disease
        name: Diabetes mellitus type 2
    reference: https://go.drugbank.com/drugs/DB11824#mechanismofaction
-   directed: true
    graph:
        drug: Simvastatin
        drugbank: DB:DB00641
        drug_mesh: MESH:D019821
        disease: Hypercholesterolemia
        disease_mesh: MESH:D006937
    links:
    -   key: decreases activity of
        source: MESH:D019821
        target: UniProt:P04035
    -   key: negatively regulates
        source: UniProt:P04035
        target: REACT:R-HSA-191273
    -   key: decreases abundance of
        source: REACT:R-HSA-191273
        target: MESH:D002784
    -   key: contributes to
        source: MESH:D002784
        target: MESH:D006937
    multigraph: true
    nodes:
    -   id: MESH:D019821
        label: Drug
        name: Simvastatin
    -   id: UniProt:P04035
        label: Protein
        name: HMG-CoA reductase
    -   id: REACT:R-HSA-191273
        label: Pathway
        name: Cholesterol synthesis
    -   id: MESH:D002784
        label: ChemicalSubstance
        name: Cholesterol
    -   id: MESH:D006937
        label: Disease
        name: Hypercholesterolemia
    reference: https://go.drugbank.com/drugs/DB00641#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Simvastatin
-   directed: true
    graph:
        drug: Simvastatin
        drugbank: DB:DB00641
        drug_mesh: MESH:D019821
        disease: Mixed hyperlipidemia
        disease_mesh: MESH:D006950
    links:
    -   key: decreases activity of
        source: MESH:D019821
        target: UniProt:P04035
    -   key: negatively regulates
        source: UniProt:P04035
        target: REACT:R-HSA-191273
    -   key: decreases abundance of
        source: REACT:R-HSA-191273
        target: MESH:D002784
    -   key: negatively regulates
        source: UniProt:P04035
        target: REACT:R-HSA-8866423
    -   key: decreases abundance of
        source: REACT:R-HSA-8866423 
        target: MESH:D008077
    -   key: contributes to
        source: MESH:D008077
        target: MESH:D006950
    -   key: contributes to
        source: MESH:D002784
        target: MESH:D006950
    multigraph: true
    nodes:
    -   id: MESH:D019821
        label: Drug
        name: Simvastatin
    -   id: UniProt:P04035
        label: Protein
        name: HMG-CoA reductase
    -   id: REACT:R-HSA-191273
        label: Pathway
        name: Cholesterol synthesis
    -   id: REACT:R-HSA-8866423
        label: Pathway
        name: Very low density lipoprotein (VLDL) synthesis
    -   id: MESH:D002784
        label: ChemicalSubstance
        name: Cholesterol
    -   id: MESH:D008077
        label: ChemicalSubstance
        name: Low density lipoprotein-cholesterol (LDL-C)
    -   id: MESH:D006950
        label: Disease
        name: Mixed hyperlipidemia
    reference: https://go.drugbank.com/drugs/DB00641#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Simvastatin
-   directed: true
    graph:
        drug: Simvastatin
        drugbank: DB:DB00641
        drug_mesh: MESH:D019821
        disease: Hypertriglyceridemia
        disease_mesh: MESH:D015228
    links:
    -   key: decreases activity of
        source: MESH:D019821
        target: UniProt:P04035
    -   key: decreases abundance of
        source: UniProt:P04035
        target: MESH:D014280
    -   key: contributes to
        source: MESH:D014280
        target: MESH:D015228
    multigraph: true
    nodes:
    -   id: MESH:D019821
        label: Drug
        name: Simvastatin
    -   id: UniProt:P04035
        label: Protein
        name: HMG-CoA reductase
    -   id: MESH:D014280
        label: ChemicalSubstance
        name: Triglyceride
    -   id: MESH:D015228
        label: Disease
        name: Hypertriglyceridemia
    reference: https://go.drugbank.com/drugs/DB00641#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Simvastatin
-   directed: true
    graph:
        drug: Simvastatin
        drugbank: DB:DB00641
        drug_mesh: MESH:D019821
        disease: Hypoalphalipoproteinemia
        disease_mesh: MESH:D052456
    links:
    -   key: decreases activity of
        source: MESH:D019821
        target: UniProt:P04035
    -   key: increases abundance of
        source: UniProt:P04035
        target: MESH:D008075
    -   key: contributes to
        source: MESH:D008075
        target: MESH:D052456
    multigraph: true
    nodes:
    -   id: MESH:D019821
        label: Drug
        name: Simvastatin
    -   id: UniProt:P04035
        label: Protein
        name: HMG-CoA reductase
    -   id: MESH:D008075
        label: ChemicalSubstance
        name: High density lipoprotein-cholesterol (HDL-C)
    -   id: MESH:D052456
        label: Disease
        name: Hypoalphalipoproteinemia
    reference: https://go.drugbank.com/drugs/DB00641#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Simvastatin
-   directed: true
    graph:
        drug: Simvastatin
        drugbank: DB:DB00641
        drug_mesh: MESH:D019821
        disease: Familial type 3 hyperlipoproteinemia
        disease_mesh: MESH:D006952
    links:
    -   key: decreases activity of
        source: MESH:D019821
        target: UniProt:P04035
    -   key: decreases abundance of
        source: UniProt:P04035
        target: MESH:D001055
    -   key: contributes to
        source: MESH:D001055
        target: MESH:D006952
    multigraph: true
    nodes:
    -   id: MESH:D019821
        label: Drug
        name: Simvastatin
    -   id: UniProt:P04035
        label: Protein
        name: HMG-CoA reductase
    -   id: MESH:D001055
        label: ChemicalSubstance
        name: Apolipoprotein B (apoB)
    -   id: MESH:D006952
        label: Disease
        name: Familial type 3 hyperlipoproteinemia
    reference: https://go.drugbank.com/drugs/DB00641#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Simvastatin
-   directed: true
    graph:
        drug: Simvastatin
        drugbank: DB:DB00641
        drug_mesh: MESH:D019821
        disease: Cerebrovascular accident
        disease_mesh: MESH:D020521
    links:
    -   key: decreases activity of
        source: MESH:D019821
        target: UniProt:P04035
    -   key: negatively regulates
        source: UniProt:P04035
        target: REACT:R-HSA-191273
    -   key: decreases abundance of
        source: REACT:R-HSA-191273
        target: MESH:D002784
    -   key: prevents
        source: MESH:D002784
        target: HP:0007201
    -   key: correlated with
        source: HP:0007201
        target: MESH:D020521
    multigraph: true
    nodes:
    -   id: MESH:D019821
        label: Drug
        name: Simvastatin
    -   id: UniProt:P04035
        label: Protein
        name: HMG-CoA reductase
    -   id: REACT:R-HSA-191273
        label: Pathway
        name: Cholesterol synthesis
    -   id: MESH:D002784
        label: ChemicalSubstance
        name: Cholesterol
    -   id: HP:0007201
        label: PhenotypicFeature
        name: Cerebral artery plaque formation
    -   id: MESH:D020521
        label: Disease
        name: Cerebrovascular accident
    reference: https://go.drugbank.com/drugs/DB00641#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Simvastatin https://pubmed.ncbi.nlm.nih.gov/15083596/#:~:text=Epidemiological%20studies%20indicate%20that%20high,the%20frequency%20of%20hemorrhagic%20stroke.
-   directed: true
    graph:
        drug: Simvastatin
        drugbank: DB:DB00641
        drug_mesh: MESH:D019821
        disease: Arteriosclerotic vascular disease
        disease_mesh: MESH:D001161
    links:
    -   key: decreases activity of
        source: MESH:D019821
        target: UniProt:P04035
    -   key: negatively regulates
        source: UniProt:P04035
        target: REACT:R-HSA-191273
    -   key: decreases abundance of
        source: REACT:R-HSA-191273
        target: MESH:D002784
    -   key: prevents
        source: MESH:D002784
        target: HP:0002621
    -   key: correlated with
        source: HP:0002621
        target: MESH:D001161
    multigraph: true
    nodes:
    -   id: MESH:D019821
        label: Drug
        name: Simvastatin
    -   id: UniProt:P04035
        label: Protein
        name: HMG-CoA reductase
    -   id: REACT:R-HSA-191273
        label: Pathway
        name: Cholesterol synthesis
    -   id: MESH:D002784
        label: ChemicalSubstance
        name: Cholesterol
    -   id: HP:0002621
        label: PhenotypicFeature
        name: atherosclerotic plaque formation
    -   id: MESH:D001161
        label: Disease
        name: Arteriosclerotic vascular disease
    reference: https://go.drugbank.com/drugs/DB00641#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Simvastatin https://pubmed.ncbi.nlm.nih.gov/15083596/#:~:text=Epidemiological%20studies%20indicate%20that%20high,the%20frequency%20of%20hemorrhagic%20stroke.
-   directed: true
    graph:
        drug: Pipotiazine palmitate
        drugbank: DB:DB01621
        drug_mesh: NULL
        disease: Schizophrenia
        disease_mesh: MESH:D012559
    links:
    -   key: decreases activity of
        source: DB:DB01621
        target: InterPro:IPR000929
    -   key: located in
        source: InterPro:IPR000929
        target: UBERON:0000349
    -   key: regulates
        source: UBERON:0000349
        target: GO:0004952
    -   key: decreases activity of
        source: DB:DB01621
        target: InterPro:IPR002231
    -   key: located in
        source: InterPro:IPR002231
        target: UBERON:0000956
    -   key: regulates
        source: UBERON:0000956
        target: GO:0004952
    -   key: positively regulates
        source: GO:0004952
        target: HP:0000708
    -   key: manifestation of
        source: HP:0000708
        target: MESH:D012559
    multigraph: true
    nodes:
    -   id: DB:DB01621
        label: Drug
        name: Pipotiazine palmitate
    -   id: InterPro:IPR000929
        label: GeneFamily
        name: Dopamine receptor family
    -   id: UBERON:0000349
        label: GrossAnatomicalStructure
        name: Limbic system
    -   id: InterPro:IPR002231
        label: GeneFamily
        name: 5-hydroxytryptamine receptor family
    -   id: UBERON:0000956
        label: GrossAnatomicalStructure
        name: Cerebral cortex
    -   id: GO:0004952
        label: BiologicalProcess
        name: Dopamine neurotransmitter receptor activity
    -   id: HP:0000708
        label: PhenotypicFeature
        name: Behavioral abnormality
    -   id: MESH:D012559
        label: Disease
        name: Schizophrenia
    reference: https://go.drugbank.com/drugs/DB01621#mechanismofaction https://academic.oup.com/bmb/article/114/1/169/246291
-   directed: true
    graph:
        drug: Perindopril
        drugbank: DB:DB00790
        drug_mesh: MESH:D020913
        disease: Hypertensive disorder
        disease_mesh: MESH:D006973
    links:
    -   key: has metabolite
        source: MESH:D020913
        target: MESH:C053500
    -   key: decreases activity of
        source: MESH:C053500
        target: UniProt:P12821
    -   key: negatively regulates
        source: UniProt:P12821
        target: REACT:R-HSA-2022377
    -   key: prevents
        source: REACT:R-HSA-2022377
        target: GO:0042310
    -   key: negatively regulates
        source: UniProt:P12821
        target: GO:0035932
    -   key: located in
        source: GO:0035932
        target: UBERON:0001235
    -   key: positively regulates
        source: UBERON:0001235
        target: GO:0003095   
    -   key: negatively regulates
        source: GO:0003095
        target: HP:0000822
    -   key: negatively regulates
        source: GO:0042310
        target: HP:0000822
    -   key: correlated with
        source: HP:0000822
        target: MESH:D006973
    multigraph: true
    nodes:
    -   id: MESH:D020913
        label: Drug
        name: Perindopril
    -   id: MESH:C053500
        label: Drug
        name: Perindoprilat
    -   id: UniProt:P12821
        label: Protein
        name: Angiotensin-converting enzyme
    -   id: REACT:R-HSA-2022377
        label: Pathway
        name: Renin-angiotensin-aldosterone system
    -   id: GO:0042310
        label: BiologicalProcess
        name: Vasoconstriction
    -   id: GO:0035932
        label: BiologicalProcess
        name: Aldosterone secretion
    -   id: GO:0003095
        label: BiologicalProcess
        name: Pressure natriuresis
    -   id: UBERON:0001235
        label: GrossAnatomicalStructure
        name: Adrenal cortex        
    -   id: HP:0000822
        label: PhenotypicFeature
        name: Blood pressure
    -   id: MESH:D006973
        label: Disease
        name: Hypertensive disorder
    reference: https://go.drugbank.com/drugs/DB00790#mechanismofaction
-   directed: true
    comment: Paromomycin helps to treat hepatic encephalopathy by stopping the growth of certain bacteria in your intestines that make ammonia
    graph:
        drug: Paromomycin
        drugbank: DB:DB01421
        drug_mesh: MESH:D010303
        disease: Hepatic coma
        disease_mesh: MESH:D006501
    links:
    -   key: molecularly interacts with
        source: MESH:D010303
        target: MESH:D012336
    -   key: negatively regulates
        source: MESH:D012336
        target: MESH:D014176
    -   key: produces
        source: MESH:D014176
        target: GO:0030163
    -   key: causes
        source: GO:0030163
        target: GO:0001896
    -   key: in taxon
        source: GO:0001896
        target: NCBITaxon:543
    -   key: contributes to
        source: NCBITaxon:543
        target: MESH:D006501
    multigraph: true
    nodes:
    -   id: MESH:D010303
        label: Drug
        name: Paromomycin
    -   id: MESH:D012336
        label: ChemicalSubstance
        name: 16S ribosomal RNA
    -   id: MESH:D014176
        label: BiologicalProcess
        name: Protein synthesis
    -   id: GO:0030163
        label: BiologicalProcess
        name: Defective polypeptide chains
    -   id: GO:0001896
        label: BiologicalProcess
        name: Bacterial death
    -   id: NCBITaxon:543
        label: OrganismTaxon
        name: Enterobacteriaceae
    -   id: MESH:D006501
        label: Disease
        name: Hepatic coma
    reference: https://go.drugbank.com/drugs/DB01421#mechanismofaction https://www.webmd.com/drugs/2/drug-5160/paromomycin-oral/details
-   directed: true
    comment: Iproniazid is stated as Withdrawn from the Canadian market in July 1964 due to interactions with food products containing tyrosine
    graph:
        drug: Iproniazid
        drugbank: DB:DB04818
        drug_mesh: MESH:D007490
        disease: Depressive disorder
        disease_mesh: MESH:D003866
    links:
    -   key: decreases activity of
        source: MESH:D007490
        target: InterPro:IPR001613
    -   key: negatively regulates
        source: InterPro:IPR001613
        target: HP:0000716
    -   key: has metabolite
        source: MESH:D007490
        target: MESH:C044821        
    -   key: decreases activity of
        source: MESH:C044821
        target: InterPro:IPR001613
    -   key: causes
        source: HP:0000716
        target: MESH:D003866
    multigraph: true
    nodes:
    -   id: MESH:D007490
        label: Drug
        name: Iproniazid
    -   id: InterPro:IPR001613
        label: GeneFamily
        name: Monoamine oxidase
    -   id: MESH:C044821
        label: ChemicalSubstance
        name: Isopropylhydrazine
    -   id: HP:0000716
        label: PhenotypicFeature
        name: Depression
    -   id: MESH:D003866
        label: Disease
        name: Depressive disorder
    reference: https://go.drugbank.com/drugs/DB04818#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Iproniazid#section=MeSH-Pharmacological-Classification
-   directed: true
    graph:
        drug: Gabapentin
        drugbank: DB:DB00996
        drug_mesh: NULL
        disease: Restless legs
        disease_mesh: MESH:D012148
    links:
    -   key: decreases activity of
        source: DB:DB00996
        target: UniProt:Q9NY47
    -   key: decreases molecular interaction
        source: UniProt:Q9NY47
        target: InterPro:IPR018882
    -   key: decreases expression of
        source: InterPro:IPR018882
        target: UniProt:Q00975
    -   key: decreases molecular interaction
        source: UniProt:Q9NY47
        target: InterPro:IPR037440
    -   key: decreases expression of
        source: InterPro:IPR037440
        target: UniProt:Q00975
    -   key: decreases molecular interaction
        source: UniProt:Q9NY47
        target: InterPro:IPR000884
    -   key: decreases expression of
        source: InterPro:IPR000884
        target: UniProt:Q00975
    -   key: located in 
        source: UniProt:Q00975
        target: GO:0098793
    -   key: prevents
        source: GO:0098793
        target: GO:0015278
    -   key: positively regulates
        source: GO:0015278
        target: GO:0007269
    -   key: negatively regulates
        source: GO:0098793
        target: GO:0005262
    -   key: positively regulates
        source: GO:0005262
        target: GO:0007269
    -   key: ameliorates
        source: GO:0007269
        target:  HP:0012514
    -   key: correlated with
        source:  HP:0012514
        target: MESH:D012148
    multigraph: true
    nodes:
    -   id: DB:DB00996
        label: Drug
        name: Gabapentin
    -   id: UniProt:Q9NY47
        label: Protein
        name: Voltage-dependent calcium channel subunit alpha-2/delta-2
    -   id: InterPro:IPR018882
        label: GeneFamily
        name: NMDA receptors
    -   id: InterPro:IPR037440
        label: GeneFamily
        name: Neurexins
    -   id: InterPro:IPR000884
        label: GeneFamily
        name: Thrombospondins
    -   id: UniProt:Q00975
        label: Protein
        name: Voltage-gated calcium channels
    -   id: GO:0098793
        label: CellularComponent
        name: Presynapse
    -   id: GO:0015278
        label: MolecularActivity
        name: Calcium-release channel activity
    -   id: GO:0005262
        label: MolecularActivity
        name: Calcium channel activity
    -   id: GO:0007269
        label: BiologicalProcess
        name: Neurotransmitter release
    -   id:  HP:0012514
        label: PhenotypicFeature
        name: Lower limb pain
    -   id: MESH:D012148
        label: Disease
        name: Restless legs
    reference: https://go.drugbank.com/drugs/DB00996#mechanismofaction https://en.wikipedia.org/wiki/Gabapentin
-   directed: true
    graph:
        drug: Gabapentin
        drugbank: DB:DB00996
        drug_mesh: NULL
        disease: Postherpetic neuralgia
        disease_mesh: MESH:D051474
    links:
    -   key: decreases activity of
        source: DB:DB00996
        target: UniProt:Q9NY47
    -   key: decreases molecular interaction
        source: UniProt:Q9NY47
        target: InterPro:IPR018882
    -   key: decreases expression of
        source: InterPro:IPR018882
        target: UniProt:Q00975
    -   key: decreases molecular interaction
        source: UniProt:Q9NY47
        target: InterPro:IPR037440
    -   key: decreases expression of
        source: InterPro:IPR037440
        target: UniProt:Q00975
    -   key: decreases molecular interaction
        source: UniProt:Q9NY47
        target: InterPro:IPR000884
    -   key: decreases expression of
        source: InterPro:IPR000884
        target: UniProt:Q00975
    -   key: located in 
        source: UniProt:Q00975
        target: GO:0098793
    -   key: prevents
        source: GO:0098793
        target: GO:0015278
    -   key: positively regulates
        source: GO:0015278
        target: GO:0007269
    -   key: negatively regulates
        source: GO:0098793
        target: GO:0005262
    -   key: positively regulates
        source: GO:0005262
        target: GO:0007269
    -   key: ameliorates
        source: GO:0007269
        target:  HP:0012531
    -   key: correlated with
        source:  HP:0012531
        target: MESH:D051474
    multigraph: true
    nodes:
    -   id: DB:DB00996
        label: Drug
        name: Gabapentin
    -   id: UniProt:Q9NY47
        label: Protein
        name: Voltage-dependent calcium channel subunit alpha-2/delta-2
    -   id: InterPro:IPR018882
        label: GeneFamily
        name: NMDA receptors
    -   id: InterPro:IPR037440
        label: GeneFamily
        name: Neurexins
    -   id: InterPro:IPR000884
        label: GeneFamily
        name: Thrombospondins
    -   id: UniProt:Q00975
        label: Protein
        name: Voltage-gated calcium channels
    -   id: GO:0098793
        label: CellularComponent
        name: Presynapse
    -   id: GO:0015278
        label: MolecularActivity
        name: Calcium-release channel activity
    -   id: GO:0005262
        label: MolecularActivity
        name: Calcium channel activity
    -   id: GO:0007269
        label: BiologicalProcess
        name: Neurotransmitter release
    -   id:  HP:0012531
        label: PhenotypicFeature
        name: Pain
    -   id: MESH:D051474
        label: Disease
        name: Postherpetic neuralgia
    reference: https://go.drugbank.com/drugs/DB00996#mechanismofaction https://en.wikipedia.org/wiki/Gabapentin
-   directed: true
    graph:
        drug: Fosphenytoin
        drugbank: DB:DB01320
        drug_mesh: MESH:C043114
        disease: Epilepsy
        disease_mesh: MESH:D004827
    links:
    -   key: derives into
        source: MESH:C043114
        target: MESH:D010672
    -   key: decreases activity of
        source: MESH:D010672
        target: UniProt:Q14524
    -   key: increases transport of
        source: UniProt:Q14524
        target: MESH:D012964
    -   key: located in
        source: MESH:D012964
        target: UBERON:0001384
    -   key: negatively regulates
        source: UBERON:0001384
        target: GO:0099611
    -   key: ameliorates
        source: GO:0099611
        target: HP:0001250
    -   key: caused by
        source: HP:0001250
        target: MESH:D004827
    multigraph: true
    nodes:
    -   id: MESH:C043114
        label: Drug
        name: Fosphenytoin
    -   id: MESH:D010672
        label: Drug
        name: Phenytoin
    -   id: UniProt:Q14524
        label: Protein
        name: Sodium channel protein type 5 subunit alpha
    -   id: MESH:D012964
        label: ChemicalSubstance
        name: Sodium
    -   id: UBERON:0001384
        label: GrossAnatomicalStructure
        name: Primary motor cortex
    -   id: GO:0099611
        label: BiologicalProcess
        name: Action potential firing threshold
    -   id: HP:0001250
        label: PhenotypicFeature
        name: Seizure
    -   id: MESH:D004827
        label: Disease
        name: Epilepsy
    reference: https://go.drugbank.com/drugs/DB01320#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Fosphenytoin#section=Pharmacology
-   directed: true
    graph:
        drug: Fosphenytoin
        drugbank: DB:DB01320
        drug_mesh: MESH:C043114
        disease: Status epilepticus
        disease_mesh: MESH:D013226
    links:
    -   key: derives into
        source: MESH:C043114
        target: MESH:D010672
    -   key: decreases activity of
        source: MESH:D010672
        target: UniProt:Q14524
    -   key: increases transport of
        source: UniProt:Q14524
        target: MESH:D012964
    -   key: located in
        source: MESH:D012964
        target: UBERON:0001384
    -   key: negatively regulates
        source: UBERON:0001384
        target: GO:0099611
    -   key: ameliorates
        source: GO:0099611
        target: HP:0001250
    -   key: caused by
        source: HP:0001250
        target: MESH:D013226
    multigraph: true
    nodes:
    -   id: MESH:C043114
        label: Drug
        name: Fosphenytoin
    -   id: MESH:D010672
        label: Drug
        name: Phenytoin
    -   id: UniProt:Q14524
        label: Protein
        name: Sodium channel protein type 5 subunit alpha
    -   id: MESH:D012964
        label: ChemicalSubstance
        name: Sodium
    -   id: UBERON:0001384
        label: GrossAnatomicalStructure
        name: Primary motor cortex
    -   id: GO:0099611
        label: BiologicalProcess
        name: Action potential firing threshold
    -   id: HP:0001250
        label: PhenotypicFeature
        name: Seizure
    -   id: MESH:D013226
        label: Disease
        name: Status epilepticus
    reference: https://go.drugbank.com/drugs/DB01320#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Fosphenytoin#section=Pharmacology
-   directed: true
    graph:
        drug: Phenytoin
        drugbank: DB:DB00252
        drug_mesh: MESH:D010672
        disease: Epilepsy
        disease_mesh: MESH:D004827
    links:
    -   key: decreases activity of
        source: MESH:D010672
        target: UniProt:Q14524
    -   key: increases transport of
        source: UniProt:Q14524
        target: MESH:D012964
    -   key: located in
        source: MESH:D012964
        target: UBERON:0001384
    -   key: negatively regulates
        source: UBERON:0001384
        target: GO:0099611
    -   key: ameliorates
        source: GO:0099611
        target: HP:0001250
    -   key: caused by
        source: HP:0001250
        target: MESH:D004827
    multigraph: true
    nodes:
    -   id: MESH:D010672
        label: Drug
        name: Phenytoin
    -   id: UniProt:Q14524
        label: Protein
        name: Sodium channel protein type 5 subunit alpha
    -   id: MESH:D012964
        label: ChemicalSubstance
        name: Sodium
    -   id: UBERON:0001384
        label: GrossAnatomicalStructure
        name: Primary motor cortex
    -   id: GO:0099611
        label: BiologicalProcess
        name: Action potential firing threshold
    -   id: HP:0001250
        label: PhenotypicFeature
        name: Seizure
    -   id: MESH:D004827
        label: Disease
        name: Epilepsy
    reference: https://go.drugbank.com/drugs/DB00252#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Phenytoin
-   directed: true
    graph:
        drug: Phenytoin
        drugbank: DB:DB00252
        drug_mesh: MESH:D010672
        disease: Status epilepticus
        disease_mesh: MESH:D013226
    links:
    -   key: decreases activity of
        source: MESH:D010672
        target: UniProt:Q14524
    -   key: increases transport of
        source: UniProt:Q14524
        target: MESH:D012964
    -   key: located in
        source: MESH:D012964
        target: UBERON:0001384
    -   key: negatively regulates
        source: UBERON:0001384
        target: GO:0099611
    -   key: ameliorates
        source: GO:0099611
        target: HP:0001250
    -   key: caused by
        source: HP:0001250
        target: MESH:D013226
    multigraph: true
    nodes:
    -   id: MESH:D010672
        label: Drug
        name: Phenytoin
    -   id: UniProt:Q14524
        label: Protein
        name: Sodium channel protein type 5 subunit alpha
    -   id: MESH:D012964
        label: ChemicalSubstance
        name: Sodium
    -   id: UBERON:0001384
        label: GrossAnatomicalStructure
        name: Primary motor cortex
    -   id: GO:0099611
        label: BiologicalProcess
        name: Action potential firing threshold
    -   id: HP:0001250
        label: PhenotypicFeature
        name: Seizure
    -   id: MESH:D013226
        label: Disease
        name: Status epilepticus
     reference: https://go.drugbank.com/drugs/DB00252#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Phenytoin
-   directed: true
    graph:
        drug: Bretylium
        drugbank: DB:DB01158
        drug_mesh: MESH:C045166
        disease: Ventricular fibrillation
        disease_mesh: MESH:D014693
    links:
    -   key: negatively regulates
        source: MESH:C045166
        target: GO:0048243
    -   key: decreases activity of
        source: GO:0048243
        target: InterPro:IPR005821
    -   key: decreases response to
        source: InterPro:IPR005821
        target: GO:0001508
    -   key: prevents
        source: GO:0001508
        target: HP:0004308
    -   key: causes
        source: HP:0004308
        target: MESH:D014693
    multigraph: true
    nodes:
    -   id: MESH:C045166
        label: Drug
        name: Bretylium
    -   id: GO:0048243
        label: BiologicalProcess
        name: Release of norepinephrine
    -   id: InterPro:IPR005821
        label: GeneFamily
        name: Voltage-gated potassium channel
    -   id: GO:0001508
        label: BiologicalProcess
        name: Action potential
    -   id: HP:0004308
        label: PhenotypicFeature
        name: Ventricular arrhythmias
    -   id: MESH:D014693
        label: Disease
        name: Ventricular fibrillation
    reference: https://go.drugbank.com/drugs/DB01158#mechanismofaction
-   directed: true
    graph:
        drug: Phenytoin
        drugbank: DB:DB00252
        drug_mesh: MESH:D010672
        disease: Localization-related epilepsy
        disease_mesh: MESH:D004828
    links:
    -   key: decreases activity of
        source: MESH:D010672
        target: UniProt:Q14524
    -   key: increases transport of
        source: UniProt:Q14524
        target: MESH:D012964
    -   key: located in
        source: MESH:D012964
        target: UBERON:0001384
    -   key: negatively regulates
        source: UBERON:0001384
        target: GO:0099611
    -   key: ameliorates
        source: GO:0099611
        target: HP:0001250
    -   key: caused by
        source: HP:0001250
        target: MESH:D004828
    multigraph: true
    nodes:
    -   id: MESH:D010672
        label: Drug
        name: Phenytoin
    -   id: UniProt:Q14524
        label: Protein
        name: Sodium channel protein type 5 subunit alpha
    -   id: MESH:D012964
        label: ChemicalSubstance
        name: Sodium
    -   id: UBERON:0001384
        label: GrossAnatomicalStructure
        name: Primary motor cortex
    -   id: GO:0099611
        label: BiologicalProcess
        name: Action potential firing threshold
    -   id: HP:0001250
        label: PhenotypicFeature
        name: Seizure
    -   id: MESH:D004828
        label: Disease
        name: Localization-related epilepsy
    reference: https://go.drugbank.com/drugs/DB00252#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Phenytoin
-   directed: true
    graph:
        drug: Phenytoin
        drugbank: DB:DB00252
        drug_mesh: MESH:D010672
        disease: Tonic-clonic seizure
        disease_mesh: MESH:D012640
    links:
    -   key: decreases activity of
        source: MESH:D010672
        target: UniProt:Q14524
    -   key: increases transport of
        source: UniProt:Q14524
        target: MESH:D012964
    -   key: located in
        source: MESH:D012964
        target: UBERON:0001384
    -   key: negatively regulates
        source: UBERON:0001384
        target: GO:0099611
    -   key: ameliorates
        source: GO:0099611
        target: HP:0001250
    -   key: caused by
        source: HP:0001250
        target: MESH:D012640
    multigraph: true
    nodes:
    -   id: MESH:D010672
        label: Drug
        name: Phenytoin
    -   id: UniProt:Q14524
        label: Protein
        name: Sodium channel protein type 5 subunit alpha
    -   id: MESH:D012964
        label: ChemicalSubstance
        name: Sodium
    -   id: UBERON:0001384
        label: GrossAnatomicalStructure
        name: Primary motor cortex
    -   id: GO:0099611
        label: BiologicalProcess
        name: Action potential firing threshold
    -   id: HP:0001250
        label: PhenotypicFeature
        name: Seizure
    -   id: MESH:D012640
        label: Disease
        name: Tonic-clonic seizure
    reference: https://go.drugbank.com/drugs/DB00252#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Phenytoin
-   directed: true
    graph:
        drug: Phenytoin
        drugbank: DB:DB00252
        drug_mesh: MESH:D010672
        disease: Lennox-Gastaut syndrome
        disease_mesh: MESH:D065768
    links:
    -   key: decreases activity of
        source: MESH:D010672
        target: UniProt:Q14524
    -   key: increases transport of
        source: UniProt:Q14524
        target: MESH:D012964
    -   key: located in
        source: MESH:D012964
        target: UBERON:0001384
    -   key: negatively regulates
        source: UBERON:0001384
        target: GO:0099611
    -   key: ameliorates
        source: GO:0099611
        target: HP:0001250
    -   key: caused by
        source: HP:0001250
        target: MESH:D065768
    multigraph: true
    nodes:
    -   id: MESH:D010672
        label: Drug
        name: Phenytoin
    -   id: UniProt:Q14524
        label: Protein
        name: Sodium channel protein type 5 subunit alpha
    -   id: MESH:D012964
        label: ChemicalSubstance
        name: Sodium
    -   id: UBERON:0001384
        label: GrossAnatomicalStructure
        name: Primary motor cortex
    -   id: GO:0099611
        label: BiologicalProcess
        name: Action potential firing threshold
    -   id: HP:0001250
        label: PhenotypicFeature
        name: Seizure
    -   id: MESH:D065768
        label: Disease
        name: Lennox-Gastaut syndrome
    reference: https://go.drugbank.com/drugs/DB00252#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Phenytoin
-   directed: true
    graph:
        drug: Phenytoin
        drugbank: DB:DB00252
        drug_mesh: MESH:D010672
        disease: Tonic-clonic epilepsy
        disease_mesh: MESH:D004830
    links:
    -   key: decreases activity of
        source: MESH:D010672
        target: UniProt:Q14524
    -   key: increases transport of
        source: UniProt:Q14524
        target: MESH:D012964
    -   key: located in
        source: MESH:D012964
        target: UBERON:0001384
    -   key: negatively regulates
        source: UBERON:0001384
        target: GO:0099611
    -   key: ameliorates
        source: GO:0099611
        target: HP:0001250
    -   key: caused by
        source: HP:0001250
        target: MESH:D004830
    multigraph: true
    nodes:
    -   id: MESH:D010672
        label: Drug
        name: Phenytoin
    -   id: UniProt:Q14524
        label: Protein
        name: Sodium channel protein type 5 subunit alpha
    -   id: MESH:D012964
        label: ChemicalSubstance
        name: Sodium
    -   id: UBERON:0001384
        label: GrossAnatomicalStructure
        name: Primary motor cortex
    -   id: GO:0099611
        label: BiologicalProcess
        name: Action potential firing threshold
    -   id: HP:0001250
        label: PhenotypicFeature
        name: Seizure
    -   id: MESH:D004830
        label: Disease
        name: Tonic-clonic epilepsy
    reference: https://go.drugbank.com/drugs/DB00252#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Phenytoin
